Equinor ASA ADR (NYSE: EQNR): Stock That Needs Special Handling

Currently, there are 2.96B common shares owned by the public and among those 2.96B shares have been available to trade.

The company’s stock has a 5-day price change of 1.73% and -10.48% over the past three months. EQNR shares are trading -10.48% year to date (YTD), with the 12-month market performance up to 5.53% higher. It has a 12-month low price of $23.74 and touched a high of $33.31 over the same period. EQNR has an average intraday trading volume of 3.64 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 4.99%, 4.71%, and -5.30% respectively.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Institutional ownership of Equinor ASA ADR (NYSE: EQNR) shares accounts for 2.16% of the company’s 2.96B shares outstanding.

It has a market capitalization of $82.00B and a beta (3y monthly) value of 0.86. The stock’s trailing 12-month PE ratio is 7.08, while the earnings-per-share (ttm) stands at $3.90. The company has a PEG of 1.22 and a Quick Ratio of 1.60 with the debt-to-equity ratio at 0.66. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.44% over the week and 1.31% over the month.

Analysts forecast that Equinor ASA ADR (EQNR) will achieve an EPS of $0.85 for the current quarter, $0.72 for the next quarter and $3.21 for 2025. The lowest estimate earnings-per-share for the quarter is $0.85 while analysts give the company a high EPS estimate of $0.85. Earnings per share for the fiscal year are expected to decrease by -8.33%, and 2.12% over the next financial year. EPS should shrink at an annualized rate of 5.80% over the next five years, compared to 11.67% over the past 5-year period.

Looking at the support for the EQNR, a number of firms have released research notes about the stock. Morgan Stanley stated their Equal-Weight rating for the stock in a research note on February 20, 2024, with the firm’s price target at $26.40-$28.50. RBC Capital Mkts on their part issued Sector Perform rating on December 19, 2023.

Most Popular

Related Posts